Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.
- NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_assertion description "[Increased RGS17 expression in some prostate and lung cancers has been demonstrated to support cancer progression, while reduced expression of RGS17 can lead to development of chemotherapeutic resistance in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.
- NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_assertion evidence source_evidence_literature NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.
- NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_assertion SIO_000772 23734683 NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.
- NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_assertion wasDerivedFrom befree-2016 NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.
- NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_assertion wasGeneratedBy ECO_0000203 NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.
- befree-2016 importedOn "2016-02-19" NP1083210.RAsdzsSgMwDrX0iD-gkOvDMWIfgpmt70mSmwZ5dUn-X7I130_provenance.